Reviewed clinical summary · Source-linked · Educational use only

Can mHealth Improve Communication Between Patients and Providers?

Clinical Bottom Line

A secondary analysis of the DIAMANTE trial finds an adaptive texting intervention did not improve patient-provider communication in diabetes and depression. PICO summary and commentary.

Summary: In a secondary analysis of the DIAMANTE trial in patients with diabetes and depression, an adaptive text-messaging intervention did not improve patient-reported communication with their healthcare providers compared with control, with a non-significant decline over the trial.

PICO Summary

ElementDetail
Population156 patients with diabetes and depressive symptoms from safety-net clinics; San Francisco, during COVID-19.
InterventionAdaptive (algorithm-personalised) or randomly selected physical-activity text messages.
ComparisonControl group receiving no text messages.
OutcomeNo significant difference in patient-provider communication (CAHPS subscale) across the three arms. Overall a substantive but non-significant decrease in CAHPS score over 6 months (-2.6; p=0.11), with similar trends across demographic subgroups.
RCT JMIR Mhealth Uhealth · 2025

Adaptive texting and patient-provider communication

RCT secondary analysis · diabetes + depression · 6 months

Trial design
Diabetes + depression Enrolled & assessed RANDOMISED 1:1:1 Text messages Activity text messages n = 104 Control No text messages n = 52 Change in CAHPS communication score over 6 months
Change from baseline — both arms
CAHPS score Baseline 6 months -2.6 (p=0.11) Text messages Control
CAHPS change
-2.6
over 6 months
P value
0.11
non-significant
Between arms
No diff
3-arm model
Analysed
156
of 195 enrolled
⬡ Bottom Line

Adaptive activity text messages did not improve patient-reported communication with providers; overall CAHPS scores declined slightly (-2.6, p=0.11) with no difference between arms, in a pandemic-era trial.

Expert Commentary

This is a worthwhile negative secondary analysis, and I value the question behind it. Digital health is usually judged on clinical metrics, but the hypothesis here, that a texting programme might also strengthen patients’ sense of connection with their care team, is a thoughtful one, especially for underserved patients who face language, geography, and time barriers. The finding that it did not move patient-reported communication, and that scores drifted slightly downward, is honest and useful. The interpretation has to be cautious in an unusual way, though: this ran during the COVID-19 pandemic, when patient-provider relationships were disrupted for reasons that had nothing to do with the intervention, so a flat or declining communication score may reflect the era as much as the texts. It is also a secondary outcome with a modest sample. Can I use this with my patients? As a corrective to over-expectation. It reminds me that automated messaging, whatever its merits for behaviour change, is not a substitute for the human relationship, and should be positioned as a complement to, not a replacement for, direct contact. The pandemic context means the door is not fully closed, and the question deserves re-testing in calmer times.

References

Leng L, Arévalo Avalos MR, Aguilera A, Lyles CR. The impact of an adaptive mHealth intervention on improving patient-provider health care communication: secondary analysis of the DIAMANTE trial. JMIR Mhealth Uhealth. 2025;13:e64296. doi:10.2196/64296

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.